Literature DB >> 8288944

Properdin: approaching four decades of research.

K K Maves1, J M Weiler.   

Abstract

Properdin plays a key role in the alternative pathway by stabilizing the C3 convertase. This review chronicles the evolution of our knowledge of the structure and function of properdin over the 40 years since its discovery. The story begins with the first description of properdin and the controversy that ensued over its existence. Then, this review describes: the rediscovery and acceptance of properdin and the alternative pathway as important components of natural immunity; properdin structure and molecular sequence; speculations on the significance of sequence similarities to thrombospondin and other proteins, and properdin biosynthesis. Finally, this review characterizes properdin deficiency. Properdin does indeed appear to play an important role in homeostasis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8288944     DOI: 10.1007/BF02918255

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  69 in total

1.  Synthesis of factors D, B and P of the alternative pathway of complement activation, as well as of C3, by guinea-pig peritoneal macrophages in vitro.

Authors:  C Bentley; W Fries; V Brade
Journal:  Immunology       Date:  1978-12       Impact factor: 7.397

2.  The properdin system and immunity. I. Demonstration and isolation of a new serum protein, properdin, and its role in immune phenomena.

Authors:  L PILLEMER; L BLUM; I H LEPOW; O A ROSS; E W TODD; A C WARDLAW
Journal:  Science       Date:  1954-08-20       Impact factor: 47.728

3.  Localization of the properdin structural locus to Xp11.23-Xp21.1.

Authors:  D Goundis; S M Holt; Y Boyd; K B Reid
Journal:  Genomics       Date:  1989-07       Impact factor: 5.736

4.  Properties of highly purified human properdin.

Authors:  J Ensky; C F Hinz; E W Todd; R J Wedgwood; J T Boyer; I H Lepow
Journal:  J Immunol       Date:  1968-01       Impact factor: 5.422

5.  The C3-activator system: an alternate pathway of complement activation.

Authors:  O Götze; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1971-09-01       Impact factor: 14.307

6.  Studies on the sub-unit structure of human properdin.

Authors:  J O Minta; I H Lepow
Journal:  Immunochemistry       Date:  1974-07

7.  A war with the molecules: Louis Pillemer and the history of properdin.

Authors:  W D Ratnoff
Journal:  Perspect Biol Med       Date:  1980       Impact factor: 1.416

Review 8.  Presidential address to American Association of Immunologists in Anaheim, California, April 16, 1980. Louis Pillemer, Properdin, and scientific controversy.

Authors:  I H Lepow
Journal:  J Immunol       Date:  1980-08       Impact factor: 5.422

9.  Effect of proteolytic digestion on the structure and function of human properdin.

Authors:  J O Minta; E S Kunar
Journal:  J Immunol       Date:  1976-04       Impact factor: 5.422

10.  Biosynthesis of complement factor P (properdin) by the human pre-monocyte cell line (U-937).

Authors:  J O Minta
Journal:  Mol Immunol       Date:  1988-12       Impact factor: 4.407

View more
  9 in total

1.  Blocking Properdin Prevents Complement-Mediated Hemolytic Uremic Syndrome and Systemic Thrombophilia.

Authors:  Yoshiyasu Ueda; Takashi Miwa; Damodar Gullipalli; Sayaka Sato; Daisuke Ito; Hangsoo Kim; Matthew Palmer; Wen-Chao Song
Journal:  J Am Soc Nephrol       Date:  2018-06-01       Impact factor: 10.121

Review 2.  Production of complement components by cells of the immune system.

Authors:  R Lubbers; M F van Essen; C van Kooten; L A Trouw
Journal:  Clin Exp Immunol       Date:  2017-03-24       Impact factor: 4.330

3.  The role of Fcgamma receptor polymorphisms and C3 in the immune defence against Neisseria meningitidis in complement-deficient individuals.

Authors:  C A Fijen; R G Bredius; E J Kuijper; T A Out; M De Haas; A P De Wit; M R Daha; J G De Winkel
Journal:  Clin Exp Immunol       Date:  2000-05       Impact factor: 4.330

Review 4.  Properdin in complement activation and tissue injury.

Authors:  Allison M Lesher; Bo Nilsson; Wen-Chao Song
Journal:  Mol Immunol       Date:  2013-06-29       Impact factor: 4.407

5.  Glycosylated hydroxytryptophan in a mussel adhesive protein from Perna viridis.

Authors:  Hua Zhao; Jason Sagert; Dong Soo Hwang; J Herbert Waite
Journal:  J Biol Chem       Date:  2009-07-07       Impact factor: 5.157

Review 6.  Human inborn errors of immunity to infection affecting cells other than leukocytes: from the immune system to the whole organism.

Authors:  Shen-Ying Zhang; Emmanuelle Jouanguy; Qian Zhang; Laurent Abel; Anne Puel; Jean-Laurent Casanova
Journal:  Curr Opin Immunol       Date:  2019-05-20       Impact factor: 7.486

7.  Comprehensive Proteoform Characterization of Plasma Complement Component C8αβγ by Hybrid Mass Spectrometry Approaches.

Authors:  Vojtech Franc; Jing Zhu; Albert J R Heck
Journal:  J Am Soc Mass Spectrom       Date:  2018-03-12       Impact factor: 3.109

8.  Properdin: A Novel Target for Neuroprotection in Neonatal Hypoxic-Ischemic Brain Injury.

Authors:  Claudia Sisa; Qudsiyah Agha-Shah; Balpreet Sanghera; Ariela Carno; Cordula Stover; Mariya Hristova
Journal:  Front Immunol       Date:  2019-11-29       Impact factor: 7.561

9.  The role of properdin in complement-mediated renal diseases: a new player in complement-inhibiting therapy?

Authors:  Marloes A H M Michels; Elena B Volokhina; Nicole C A J van de Kar; Lambertus P W J van den Heuvel
Journal:  Pediatr Nephrol       Date:  2018-08-23       Impact factor: 3.714

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.